IMMATICS NV Share Price Today: Live Updates & Key Insights
IMMATICS NV share price today is $9.45, up -2.88%. The stock opened at $9.77 against the previous close of $9.71, with an intraday high of $9.79 and low of $9.37.
IMMATICS NV Share Price Chart
IMMATICS NV
IMMATICS NV Share Price Performance
IMMATICS NV Institutional Holdings
IMMATICS NV Market Status
IMMATICS NV Fundamentals
Market Cap 1264.53 M
PB Ratio 2.3335
PE Ratio 0.0
Enterprise Value 781.99 M
Total Assets 562.10 M
Volume 224378
IMMATICS NV Company Financials
About IMMATICS NV & investment objective
Company Information Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes Anzu-cel (IMA203), a one-time infusion PRAME cell therapy, which is in Phase 2 trial; IMA203CD8, a cell therapy product that is in Phase 1 clinical trial; IMA204 that targets tumor stroma, which is in Phase 1 clinical trial; and Anzu-cel in combination with Moderna's PRAME cell therapy enhancer (mRNA-4203), which is in Phase 1 clinical trial. The company also develops TCR Bispecifics products, including IMA401 and IMA402, which is in Phase 1a clinical trial. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.
Organisation Biotechnology
Employees 589
Industry Biotechnology
CEO Dr. Harpreet Singh Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
IMMATICS NV FAQs
What is the share price of IMMATICS NV today?
The current share price of IMMATICS NV is $9.45.
Can I buy IMMATICS NV shares in India?
Yes, Indian investors can buy IMMATICS NV shares by opening an international trading and demat account with Motilal Oswal.
How to buy IMMATICS NV shares in India?
You can easily invest in IMMATICS NV shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy IMMATICS NV shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of IMMATICS NV.
Can I buy fractional shares of IMMATICS NV?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of IMMATICS NV?
IMMATICS NV has a market cap of $1264.53 M.
In which sector does IMMATICS NV belong?
IMMATICS NV operates in the Biotechnology sector.
What documents are required to invest in IMMATICS NV stocks?
To invest, you typically need:
What is the PE and PB ratio of IMMATICS NV?
The PE ratio of IMMATICS NV is N/A and the PB ratio is 2.33.